Abstract
A new immunoaffinity solid phase extraction of morphine and its phase II metabolites, morphine-3-ß-D-glucuronide and morphine-6-ß-D-glucuronide is described. An immunoadsorber was applied which was created for the first time by the immobilisation of specific antibodies (polyclonal, host: rabbit) by the sol-gel method. The extraction method in combination with high performance liquid chromatography-fluorescence determination has been validated and shown to be applicable to blood samples of heroin victims in a low concentration range. Blood extracts were essentially free of interfering matrix components when compared to C8-extracts. Additionally, a novel, sensitive and selective detection system for wavelength-resolved analysis of laser-induced fluorescence coupled to HPLC was developed. The analytes were excited with a frequency tripled Ti:Sa laser (λ=244 nm quasi cw). The total emission spectrum was recorded with a detection system consisting of an imaging spectrograph and a back-illuminated CCD camera. This technique of detection, combined with an extended optical path (at least 6 mm could be illuminated by the laser), resulted in an optimal fluorescence intensity of the analytes. The method permitted the analysis of morphine, morphine-3-ß-D-glucuronide and morphine-6-ß-D-glucuronide in a low concentration range and could be applied to a complex matrix such as postmortem blood samples because analyte peaks could be discriminated from matrix peaks by their characteristic emission spectra.
Similar content being viewed by others
References
Aderjan R, Hoffmann S, Schmitt G, Skopp G (1995) Morphine and morphine glucuronides in serum of heroin consumers and in heroin-related deaths determined by HPLC with native fluorescence detection. J Anal Toxicol 19:163–168
Pasternak GW, Bodnar RJ, Clark JA, Inturrisi CE (1987) Morphine-6-glucuronide, a potent mu agonist. Life Sci 41:2845–2849
Gong QL, Hedner T, Hedner J, Björkmann R, Nordberg G (1991) Antinococeptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide. Eur J Pharmacol 193:47–56
Sullivan AF, McQuay HJ, Bailey D, Dickenson AH (1989) The spinal antinociceptive actions of morphine metabolites morphine-6-glucuronide and normorphine in the rat. Brain Res 482:219–224
Stain-Texier F, Boschi G, Sandouk P, Scherrmann J (1999) Elevated concentrations of morphine 6-beta-D-glucuronide in brain extracellular fluid despite low blood-brain barrier permeability. Br J Pharmacol 128:917–924
Baker L, Dye A, Ratka A (2000) Effects of morphine glucuronides on the function of opioid receptors in human SK-N-SH cells. Neurosci Lett 281:1–4
Grung M, Skurtveit S, Ripel A, Morland J (2000) Lack of crosstolerance between morphine and morphine-6-glucuronide as revealed by locomotor activity. Pharmacol Biochem Behav 66:205–210
Brown GP, Yang K, Ouerfelli O, Standifer KM, Byrd D, Pasternak GW (1997) 3H-morphine-6beta-glucuronide binding in brain membranes and an MOR-1-transfected cell line. J Pharmacol Exp Ther 282:1291–1297
Osborne R, Thompson P, Joel S, Trew D, Patel N, Slevin M (1992) The analgesic activity of morphine-6-glucuronide, Br J Clin Pharmacol 34:130–138
Geisslinger G, Brune K, Kobal G, Lötsch J (1997) Intravenous morphine-6-glucuronide (M6G) is devoid of analgesic activity in man. Pain 70:289–290
Lötsch J, Kobal G, Stockmann A, Brune K, Geisslinger G (1997) Lack of analgesic activity of morphine-6-glucuronide after short-term intravenous administration in healthy volunteers. Anesthesiology 87:1348–1358
Steentoft A, Worm K, Pedersen CB, Sprehn M, Mogensen T, Sorensen MB, Nielsen E (1996) Drugs in blood samples from unconscious drug addicts after the intake of an overdose. Int J Legal Med 108:248–251
Wright AW, Watt JA, Kennedy M, Cramond T, Smith MT (1994) Quantitation of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in plasma and cerebrospinal fluid using solid-phase extraction and high-performance liquid chromatography with electrochemical detection. Ther Drug Monit 16:200–208, erratum: Ther Drug Monit (1998) 20:218
Blanchet M, Bru G, Guerret M, Bromet-Petit M, Bromet N (1999) Routine determination of morphine, morphine-3-beta-D-glucuronide and morphine-6-beta-D-glucuronide in human serum by liquid chromatography coupled to electrospray mass spectrometry. J Chromatogr A 854:93–108
Wu WS, Tsai JL (1999) Analysis of morphine and morphine-3beta-D-glucuronide in human urine by capillary zone electrophoresis with minimal sample pretreatment. Biomed Chromatogr 13:216–219
Tsai JL, Wu WS, Lee HH (2000) Qualitative determination of urinary morphine by capillary zone electrophoresis and ion trap mass spectrometry. Electrophoresis 21:1580–1586
Manetto G, Tagliaro F, Crivellente F, Pascali VL, Marigo M (2000) Field-amplified sample stacking capillary zone electrophoresis applied to the analysis of opiate drugs in hair. Electrophoresis 21:2891–2898
Vandepeer J, Trenerry VC, Keogh G (1996) Some examples of the analysis of complex samples by micellar electrokinetic capillary chromatography with photodiode array detection. Electrophoresis 17:1361–1366
Zhang XX, Li J, Gao J, Sun L, Chang WB (2000) Determination of morphine by capillary electrophoresis immunoassay in thermally reversible hydrogel-modified buffer and laser-induced fluorescence detection. J Chromatogr A 895:1–7
Sagawa K, Kimura A, Saito Y, Inoue H, Yasuda S, Nosaka M, Tsuji T (2003) Production and characterization of a monoclonal antibody for sweat-specific protein and its application for sweat identification. Int J Legal Med 117:90–95
De Letter E, Espeel M, Craeymeersch M et al. (2003) Immunohistochemical demonstration of the amphetamine derivatives 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) in human post-mortem brain tissues and the pituitary gland. Int J Legal Med 117:2–9
Weller MG (2000) Immunographic techniques—a critical view. Fresenius J Anal Chem 366:635–645
Van Emon JM, Gerlach CL (1998) Bioseparation and bioanalytical techniques in environmental monitoring. J Chromatogr B 715:211–228
Hage DS (1998) Survey of recent advances in analytical applications of immunoaffinity chromatography. J Chromatogr B 715:3–28
Glencross RG, Abeywardene SA, Corney SJ, Morris HS (1981) The use of oestradiol-17 beta antiserum covalently coupled to Sepharose to extract oestradiol-17 beta from biological fluids. J Chromatogr 223:193–197
Rashid BA, Kwasowski P, Stevenson D (1999) Solid phase extraction of clenbuterol from plasma using immunoaffinity followed by HPLC. J Pharm Biomed Anal 21:635–639
Maurer HH, Schmitt CJ, Weber AA, Kraemer T (2000) Validated electrospray liquid chromatographic-mass spectrometric assay for the determination of the mushroom toxins a- and ß-amanitin in urine after immunoaffinity extraction. J Chromatogr B 748:125–135
Lemm U, Tenczer J, Baudisch H, Krause W (1985) Antibody-mediated extraction of the main tetrahydrocannabinol metabolite, 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid, from human urine and its identification by gas chromatography-mass spectrometry in the sub-nanogram range. J Chromatogr 342:393–398
Feng S, El Solhly MA, Salamone S, Salem MY (2000) Simultaneous analysis of delta9-THC and its major metabolites in urine, plasma, and meconium by GC-MS using an immunoaffinity extraction procedure. J Anal Toxicol 24:395–402
Franzelius C, Ackermann I, Deinl I, Angermaier L, Machbert G (1998) Simultaneous extraction of selected benzodiazepines and benzodiazepine-glucuronides from urine by immunoadsorption. J Anal Toxicol 22:359–362
Deinl I, Franzelius C, Angermaier L, Mahr G, Machbert G (1999) On-line immunoaffinity extraction and HPLC analysis of flunitrazepam and its main metabolites in serum, J Anal Toxicol 23:598–602
Kerrigan S, Brooks DE (1999) Immunochemical extraction and detection of LSD in whole blood. J Immunol Methods 224:11–18
Röhrich J, Zörntlein S, Becker J (2000) Analysis of LSD in human body fluids and hair samples applying ImmunElute columns. Forensic Sci Int 107:181–190
Beike J, Köhler H, Blaschke G (1997) Antibody-mediated clean-up of blood for simultaneous HPLC determination of morphine and morphine glucuronides. Int J Legal Med 110:226–229
Beike J, Köhler H, Brinkmann B, Blaschke G (1999) Immunoaffinity extraction of morphine, morphine-3-glucuronide and morphine-6-glucuronide from blood of heroin victims for simultaneous high-performance liquid chromatographic determination. J Chromatogr B 726:111–119
Beike J, Blaschke G, Mertz A, Köhler H, Brinkmann B (1998) A specific immunoassay for the determination of morphine and its glucuronides in human blood. Int J Legal Med 112:8–14
Spitzer B, Cichna M, Markl P, Sontag G, Knopp D, Niessner R (2000) Determination of 1-nitropyrene in herbs after selective enrichment by a sol-gel-generated immunoaffinity column. J Chromatogr A 880:113–120
Brown RE, Jarvis KL, Hyland KJ (1989) Protein measurement using bicinchoninic acid: elimination of interfering substances. Anal Biochem 180:136–139
US Department of Health and Human Services, Food and Drug Administration, Center of Drug Evaluation and Research, Center of Veterinary Medicine, Guidance for Industry, Bioanalytical Validation, May 2001, BP
Schmitt G, Bogusz M, Aderjan R, Meyer C (1990) Detection of morphine and codeine in blood samples with gas chromatography/mass spectrometry (NCI and PCI) for differentiating codeine use from use of heroin and morphine. Z Rechtsmed: 103:513–521
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hupka, Y., Beike, J., Roegener, J. et al. HPLC with laser-induced native fluorescence detection for morphine and morphine glucuronides from blood after immunoaffinity extraction. Int J Legal Med 119, 121–128 (2005). https://doi.org/10.1007/s00414-004-0501-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00414-004-0501-0